News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
Katharine Lewis: Our practice has changed- minimal use of High-Dose Methotrexate in Central Nervous System prophylaxis in aggressive Non-Hodgkin lymphoma (aNHL).
Photo of Katharine Lewis taken from bloodcancerwa.org.au
Oct 9, 2023, 19:02

Katharine Lewis: Our practice has changed- minimal use of High-Dose Methotrexate in Central Nervous System prophylaxis in aggressive Non-Hodgkin lymphoma (aNHL).

Quoting Katharine Lewis, Haematology Fellow at Sir Charles Gairdner Hospital, on X/Twitter:

“Delighted to share our work now published on behalf of all co-authors. Our practice has changed- minimal use of High-Dose Methotrexate in Central Nervous System (CNS) prophylaxis in aggressive non-Hodgkin lymphoma (aNHL). Thank you so much to all international collaborators!”

For the article click here.
Source: Katharine Lewis/Twitter

 

cancer Katharine Lewis methotrexate Non Hodgkin lymphoma OncoDaily Oncology Sir Charles Gairdner Hospital
Special Coverage
Blog
Nov 13, 2024, 09:55
Moderna Incorporation announced the awardees of its 2024 Australia Fellowship Program
Blog
Nov 13, 2024, 09:39
AI tools to improve diagnosis and therapy in neuro-oncology
Insight
Nov 13, 2024, 09:27
Nikki Rossetti et al. on Early-Stage Lung Cancer in the Era of Lung Cancer Screening
Blog
Nov 13, 2024, 09:14
Yüksel Ürün: Key takeaways on high-risk and locally advanced prostate cancer from António Rui Azevedo Freitas
Blog
Nov 13, 2024, 09:11
Clinical outcomes of early-stage triple-negative breast cancer after neoadjuvant chemotherapy
Blog
Nov 13, 2024, 09:09
Yüksel Ürün: Not all that shines is Prostate cancer – a striking reminder from Daniela Oprea-Lager
Blog
Nov 13, 2024, 09:01
Updated Results with Mitazalimab as a first-line treatment for advance pancreatic cancer
Blog
Nov 13, 2024, 08:59
Miriam Mutebi: What To Expect During A Mammogram
Insight
Nov 13, 2024, 08:56
Rachel Riechelmann: Low dose Everolimus for patients with Neuroendocrine tumors
Insight
Nov 13, 2024, 08:51
Reporting pharmacogenetic variants and cancer WGS data could guide safer prescribing
Blog
Nov 13, 2024, 08:49
Yüksel Ürün: Promising findings on SGLT2 as a biomarker for papillary RCC by Erman Akkus
Blog
Nov 13, 2024, 08:46
Karen Knudsen: Better Together - Partnering to Accelerate Progress against Cancer